Format

Send to

Choose Destination
World J Urol. 2018 Oct 4. doi: 10.1007/s00345-018-2509-y. [Epub ahead of print]

Aquablation of the prostate: single-center results of a non-selected, consecutive patient cohort.

Author information

1
Department of Urology, Asklepios Hospital Harburg, Eissendorfer Pferdeweg 52, 22559, Hamburg, Germany. t.bach@asklepios.com.
2
Department of Urology, Kantonspital Frauenfeld, Kanton Thurgau, Switzerland.
3
European Association of Urology Section of Urotechnology (ESUT)-Lower Tract Working Group, Arnhem, The Netherlands.

Abstract

PURPOSE:

Aquablation of the prostate using the AquaBeam™ system promises equivalent functional outcomes, reduced learning curve, and improved sexual function compared to transurethral prostate resection as shown in prospective randomized trials. This prospective cohort study aims to evaluate if published results can be transferred into the clinical routine in a non-selected patient collective.

METHODS:

This study includes all patients treated between September 2017 and June 2018 with Aquablation of the prostate. Patients have been evaluated prospectively for the perioperative course and early follow-up. Besides voiding parameter and symptom score, TRUS-volume change, ejaculatory function, and adverse events have been recorded.

RESULTS:

118 consecutive patients have been treated in the given time. Aquablation could be carried out successfully in all patients. IPSS, QoL, Qmax, and PVR improved significantly after the procedure and continued to improve during 3-month follow-up. Mean OR time was 20 min, TRUS volume decreased by 65%, and 73% of the patients retained antegrade ejaculation. Thirteen adverse events (> Clavien-Dindo I) occurred in 10 patients.

CONCLUSION:

The surgical ablation of the prostate using Aquablation achieved significant and immediate improvement of functional voiding parameters Qmax and PVR as well as symptomatic improvement of IPSS and QoL. Aquablation seems to be safe and effective with a low perioperative complication profile even in a non-selected group of patients.

KEYWORDS:

AquaBeam; Aquablation; BPH; BPO; Waterjet

PMID:
30288598
DOI:
10.1007/s00345-018-2509-y

Supplemental Content

Full text links

Icon for Springer
Loading ...
Support Center